These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 8702227
1. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats. Yoshida M, Fujioka A, Nakano K, Kobunai T, Saito H, Toko T, Takeda S, Unemi N. Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227 [Abstract] [Full Text] [Related]
3. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA, Sirotnak FM, Otter GM, DeGraw JI. Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784 [Abstract] [Full Text] [Related]
4. Prediction of the optimum clinical dosing schedule for menogaril from results with tumor-bearing mice. Yoshida M, Kobunai T, Nakano K, Saito H, Toko T, Takeda S, Unemi N. Anticancer Res; 1996; 16(5A):2869-73. PubMed ID: 8917400 [Abstract] [Full Text] [Related]
5. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines. Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N. Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873 [Abstract] [Full Text] [Related]
6. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review. Holmes FA. Semin Oncol; 1996 Oct 01; 23(5 Suppl 11):46-56. PubMed ID: 8893900 [Abstract] [Full Text] [Related]
10. Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice. Haga S, Shimizu T, Imamura H, Watanabe O, Kinoshita J, Fukushima M, Kajiwara T. Anticancer Res; 1999 Oct 01; 19(3A):1791-6. PubMed ID: 10470117 [Abstract] [Full Text] [Related]
12. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells. Watanabe M, Komeshima N, Nakajima S, Tsuruo T. Cancer Res; 1988 Dec 01; 48(23):6653-7. PubMed ID: 3180075 [Abstract] [Full Text] [Related]
14. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine. Cao S, McGuire JJ, Rustum YM. Clin Cancer Res; 1999 Jul 01; 5(7):1925-34. PubMed ID: 10430100 [Abstract] [Full Text] [Related]
19. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo. Saikawa Y, Kubota T, Kuo TH, Furukawa T, Kase S, Tanino H, Ishibiki K, Kitajima M, Hoffman RM. Anticancer Res; 1994 Jul 01; 14(2A):469-73. PubMed ID: 8017850 [Abstract] [Full Text] [Related]